EVOLENT HEALTH INC CLASS A overview

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1 PR Newswire WASHINGTON, Dec. 18, 2024 Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus. WASHINGTON , Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025 . Dr. Nguyen joined Evolent as...

Evolent Announces Third Quarter 2024 Results PR Newswire WASHINGTON, Nov. 7, 2024 Revenue of $621.4 million , an increase of $110.4 million or 21.6% , from the three months ended September 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) million and a net loss margin of (5.0)% . Adjusted EBITDA of $31.8 million resulting in an Adjusted EBITDA margin of 5.1% . Revises outlook for Adjusted EBITDA for 2024. Reiterates average annual long-term revenue and...

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 PR Newswire WASHINGTON, Oct. 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON , Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2024 financial results on Thursday,...

Evolent Announces Second Quarter 2024 Results PR Newswire WASHINGTON, Aug. 8, 2024 Revenue of $647.1 million , an increase of $178.0 million or 37.9% , from the three months ended June 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and a net loss margin of (1.0)% . Adjusted EBITDA of $52.0 million resulting in an Adjusted EBITDA margin of 8.0% . Narrows revenue outlook for full year 2024 and provides updated 2024 Adjusted EBITDA guidance....

Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 PR Newswire WASHINGTON, July 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 financial results on Thursday,...

Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify PR Newswire WASHINGTON, June 4, 2024 Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automation Machinify technology leverages the latest advances in applied machine learning, large language models and data analytics Acquisition expected to benefit health...

Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S. PR Newswire WASHINGTON, May 9, 2024 Digital cancer care platform Careology and Evolent (NYSE: EVH) to offer an innovative platform to enable cancer navigation Evolent will embed Careology's digital cancer care technology within its comprehensive care navigation services offered to health plan clients across the U.S. WASHINGTON , May 9, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a $2...

Evolent Announces First Quarter 2024 Results PR Newswire WASHINGTON, May 9, 2024 Revenue of $639.7 million , an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million and a net loss margin of (3.9)%. Adjusted EBITDA of $54.1 million resulting in an Adjusted EBITDA margin of 8.5%. Raises revenue outlook for full year 2024 and reiterates full year 2024 Adjusted EBITDA guidance....